SHINE: SHINE and Sumitomo Corporation of Americas Announce Partnership to Expand Medical Isotope and Fusion Technology Distribution in Asian Markets

Strategic alliance set to strengthen supply chains for medical isotopes, industrial applications, and fusion technologies between North America and Asia, supporting SHINE's global expansionJANESVILLE, Wis., April 8, 2025 /PRNewswire/ -- SHINE Technologies, a next-generation fusion company, today announced a strategic partnership with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company. The partnership, formalized through a Memorandum of Understanding (MOU), will explore and develop pathways for SCOA to promote and distribute SHINE's innovative products and services throughout Japan and other Asian markets.SHINE and Sumitomo partner to expand fusion technologies across Asian marketsStrengthening Global Supply Chains for Critical Medical Isotopes and Advanced Fusion ApplicationsThis collaboration will focus on establishing reliable supply chains for SHINE's portfolio of products and services, including critical medical isotopes like lutetium-177 and molybdenum-99, neutron imaging for industrial inspection, and advanced materials testing. The agreement also lays the groundwork for studying logistics and legal requirements to transport radioisotopes and related ...Full story available on Benzinga.com